alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM (A) THE JUNE
30, 1998 FINANCIAL STATEMENTS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH (B) FINANCIAL STATEMENTS.
</LEGEND>
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1998
<PERIOD-START>                             APR-01-1998
<PERIOD-END>                               JUN-30-1998
<CASH>                                         619,260
<SECURITIES>                                         0
<RECEIVABLES>                                1,189,923
<ALLOWANCES>                                         0
<INVENTORY>                                    100,944
<CURRENT-ASSETS>                             2,290,278
<PP&E>                                       1,172,094
<DEPRECIATION>                                 643,686
<TOTAL-ASSETS>                               3,626,909
<CURRENT-LIABILITIES>                        1,390,540
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                        600
<COMMON>                                       214,423
<OTHER-SE>                                   2,021,346
<TOTAL-LIABILITY-AND-EQUITY>                 3,626,909
<SALES>                                        674,577
<TOTAL-REVENUES>                               674,577
<CGS>                                          (9,931)
<TOTAL-COSTS>                                  (9,931)
<OTHER-EXPENSES>                           (1,743,325)
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                             (4,426)
<INCOME-PRETAX>                            (1,083,105)
<INCOME-TAX>                                   (9,228)
<INCOME-CONTINUING>                        (1,092,333)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,092,333)
<EPS-PRIMARY>                                   (0.07)
<EPS-DILUTED>                                   (0.07)
        

</TABLE>
EXHIBIT 32.1




CERTIFICATION OF CHIEF EXECUTIVE OFFICER
  PURSUANT TO 18 U.S.C. SECTION 1350,
  AS ADOPTED PURSUANT TO
  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  In connection with the Annual Report of Scivanta Medical Corporation (the “Company”) on Form 10-K for the fiscal year ended October 31, 2010, as filed with the Securities and Exchange Commission (the “Report”), I, David R. LaVance, President and Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:
  (1)
the Report fully complies with the requirements of §13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, 15 U.S.C. §78m or 78o(d), and,
 (2)
the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
  Date:  February 15, 2011                                                                           By: /s/ David R. LaVance
 David R. LaVance
 President and Chief Executive Officer
# Sitemap

## January 31, 2015

- Home
- Sitemap
- 2015
- 01
- January 31, 2015

            - Delta II Two-stage Launch Vehicle
            - SMAP Takes to the Skies
            - Propellant Loaded for Delta II
            - NASA Launches Groundbreaking Soil Moisture Mapping Satellite
            - NASA Launches Groundbreaking Soil Moisture Mapping Satellite
            - NASA Talk Looks at the F-22 From a Pilot’s Perspective
1 In The



### Court of Appeals

Ninth District of Texas at Beaumont

____________________

NO

. 09

- 1 3

- 00 098

- C R



### ____________________

IN RE DWAYNE T. DAVIS

________________________________________ _______________ ______________

Original Proceeding

________________________________________ ________________ _____________

MEMORANDUM OPINION

Dwayne T. Davis filed a petition for writ of mandamus in which he seeks to

compel the trial court to vacate an order denying Davis’s request for time credit on

his sentence for possession of a deadly weapon in a penal institution and to sign a

judgment nunc pro tunc giving Davis credit on his sentence from th e date of his

arrest, July 18, 1996, t o th e date of his indictment, June 5 , 1997

. “A motion for

judgment nunc pro tunc or a writ of mandamus to the appellate court if such a

motion is denied will provide a remedy only if the right to pre

- trial jail

- time credit

is absolutely indisputable under the terms of Article 42.03, Section 2(a)(1).” In re2

Brown , 343 S.W.3d 803, 804 (Tex. Crim. App. 2011) ; see also Tex. Code Crim.

Proc. Ann. art. 42.03, § 2(a)(1) (West Supp. 2012)

. A prisoner confined by another

jurisdiction is confined for purposes of article 42.03 “only if a detainer or hold is

lodged against him.” Nixon v. State

, 572 S.W.2d 699, 701 (Tex. Crim. App. 1978).

Davis has not shown that he was in constructive custody of Polk County when he

was confined in prison prior to his ind ictment in this case

. See Ex parte Kuban , 763

S.W.2d 426, 427 (Tex. Crim. App. 1989). Davis failed to establish that he has a

right to relief. Accordingly, the petition for writ of mandamus is denied.

PETITION DENIED.

PER CURIAM

Opinion Delivered March 27, 2013

Do not Publish

Before McKeithen, C.J., Kreger and Horton, JJ.
fmnb-ex101_62.htm



Exhibit 10.1

 


	
	
Notice of Grant of

Restricted Stock Award, 

Performance-based Equity Award, and 

Performance-based Cash Award

	
Name

Address

City, State Zip




Subject to the terms and conditions of the 2017 Equity Incentive Plan and the Farmers National Banc Corp. Long-Term Incentive Plan (the “Plans”) and the accompanying Restricted Stock Award Agreement, Performance-based Equity Award Agreement, and Performance-based Cash Award Agreement (the “Award Agreements”), you have been granted Shares of Restricted Stock, Performance-based Shares, and a Performance-based Cash Award (collectively, the “Awards”) as follows:


		
	
Grant Date:
	
February 18, 2020

	
Number of Shares:
	
Your Awards consist of the following:

      Shares of Restricted Stock 1

      Performance-based Shares 2

$ __Target Performance-based Cash 3

	
Vesting Schedule:
	
Your Awards of Shares of Restricted Stock, Performance-based Shares, and Performance-based Cash will be subject to vesting on February 18, 2022 (Normal Vesting Date).

	
Settlement:
	
Your Awards will be settled in Shares or Cash, depending on the Award, as described in the respective Award Agreements.




This Notice of Grant and the accompanying Award Agreements describe your Awards and the terms and conditions of your Awards.  To ensure you fully understand these terms and conditions, you should:


	
 
	
•
	
Read the Plan carefully to ensure you understand how the Plans work; and





	
 
	
•
	
Read this Notice of Grant and corresponding Award Agreement carefully to ensure you understand the nature of your Award and what you must do to earn it.  




You may contact Mark Nicastro by telephone (330-533-5025) or email (mnicastro@farmersbankgroup.com) if you have any questions about your Award or Award Agreement.

 

 

	
	 





	
1 
	
 Number of Shares of Restricted Stock were determined by multiplying $____ (the dollar amount used to determine your total target Awards) by .25, and dividing the result by $____ (the average reported closing price of a Share during the 30-day period ending on the last trading day prior to the Grant Date). The resulting number of Shares were rounded to the nearest whole Share.





	
2 
	
 Number of Performance-based Shares were determined by multiplying $____ by .5, dividing the result by $___ (to determine the target number of Performance-based Shares), and multiplying the result by 2 (to determine the maximum number of Performance-based Shares). The resulting number of Performance-based Shares were rounded to the nearest whole Share.





	
3 
	
 Your target Performance-based Cash Award was determined by multiplying $____ by .25.
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; National Biocontainment Laboratories (NBLs) Operations Support.                    

*Date:*                         November 17, 2010.                    

*Time:*                         1 p.m. to 6 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817. (Telephone Conference Call)                    

*Contact Person:*                         Peter R. Jackson, Ph.D., Scientific Review Administrator, Scientific Review Program, Division of Extramural Activities, NIAID, NIH, Room 2217, 6700-B Rockledge Drive, MSC, 7616, Bethesda, MD 20892-7616, 301-496-2550,                         *pj8v@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: October 20, 2010.

Jennifer S. Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 2010-27053 Filed 10-25-10; 8:45 am]

BILLING CODE 4140-01-P
No. 87-1301.

#### Holland *v.*District Court, County of Douglas, Colorado, et al.

C. A. 10th Cir. Certiorari denied.
<PAGE>   1
                                                                  EXHIBIT 10.178


                                  DEMAND NOTE

$351,000.00                                                   New York, New York
                                                              July 5, 2000

        FOR VALUE RECEIVED, the undersigned, Wilshire Technologies, Inc. a
California corporation (hereinafter referred to as "Borrower"), hereby
unconditionally PROMISES TO PAY to the order to TRILON DOMINION PARTNERS, LLC, a
Delaware limited liability company ("Lender"), at 245 Park Avenue, 28th Floor,
New York, NY 10167, or at such other place as the holder of this Demand Note may
designate from time to time in writing, in lawful money of the United States of
America and in immediately available funds, the principal amount of Three
Hundred Fifty-one Thousand and 00/100, DOLLARS ($351,000.00), together with
interest on the unpaid principal amount of this Demand Note outstanding from
time to time from the date hereof, at a rate per annum equal to the Prime rate
of interest plus 3.0%, or the highest rate permitted by law, whichever shall be
less.

        The principal amount of the indebtedness evidenced hereby shall be
payable on demand. Interest thereon shall be paid when principal is paid from
the date hereof until such principal amount is paid in full at such interest
rate as specified above. Following failure to pay on demand, Borrower agrees to
pay interest on any overdue payment of principal at a rate per annum equal to
the stated interest rate plus 5%, or the highest rate permitted by law,
whichever shall be less. All interest calculations shall be computed on the
basis of a 360 day year.

        Demand, presentment, protest and notice of nonpayment and protest are
hereby waived by Borrower.

        Borrower shall have no right to make any off-set against or deduct from
any payment due under this Demand Note.

        Principal and interest may be prepaid at any time without penalty.

        This Demand Note may not be changed orally, but only by an agreement in
writing and signed by the party against whom enforcement of such change is
sought.

        All covenants of Borrower in this Demand Note and all rights of the
holder under this Demand Note shall bind Borrower and its successors and
assigns, and all such covenants and rights shall inure to the benefit of the
holder of this Demand Note and its successors and assigns.

        This Demand Note has been delivered and accepted at New York, New York
and shall be interpreted, governed by, and construed in accordance with, the
laws of the State of New York.

                                           Wilshire Technologies, Inc.



                                           By: /s/ Kathleen E. Terry
                                               ---------------------------------
                                               Name:  Kathleen E. Terry
                                               Title: Chief Financial Officer
Presidential Documents

65935 

Federal Register 

Vol. 75, No. 206 

Tuesday, October 26, 2010 

Title 3— 

The President 

Notice of October 22, 2010 

Continuation of the National Emergency With Respect to the 

Situation in or in Relation to the Democratic Republic of the 

Congo 

On October 27, 2006, by Executive Order 13413, the President declared 

a national emergency with respect to the situation in or in relation to 

the Democratic Republic of the Congo and, pursuant to the International 

Emergency Economic Powers Act (50 U.S.C. 1701–1706), ordered related 

measures blocking the property of certain persons contributing to the conflict 

in that country. The President took this action to deal with the unusual 

and extraordinary threat to the foreign policy of the United States constituted 

by the situation in or in relation to the Democratic Republic of the Congo, 

which has been marked by widespread violence and atrocities that continue 

to threaten regional stability. 

Because this situation continues to pose an unusual and extraordinary threat 

to the foreign policy of the United States, the national emergency declared 

on October 27, 2006, and the measures adopted on that date to deal with 

that emergency, must continue in effect beyond October 27, 2010. Therefore, 

in accordance with section 202(d) of the National Emergencies Act (50 

U.S.C. 1622(d)), I am continuing for 1 year the national emergency declared 

in Executive Order 13413. 

This notice shall be published in the Federal Register and transmitted to 

the Congress. 

THE WHITE HOUSE, 

October 22, 2010. 

[FR Doc. 2010–27246 

Filed 10–25–10; 11:15 am] 

Billing code 3195–W1–P 


hsrobinson on DSK69SOYB1PROD with PROPOSALSOB#1.EPS</GPH>
**Exhibit 99.1**

 

**CERTIFICATION OF**

**CHIEF EXECUTIVEOFFICER AND PRINCIPAL ACCOUNTING OFFICER**

 

 

This certification is given bythe undersigned Chief Executive Officer and Principal Accounting Officer ofFirst Community Financial Group, Inc. (the “Registrant”) pursuant to Section906 of the Sarbanes-Oxley Act of 2002. Each of the undersigned hereby certifies, with respect to theRegistrant’s quarterly report of Form 10-Q for the period ended June 30, 2002as filed with the Securities and Exchange Commission on the date hereof (the“Report”), that:

 

(1)           The Report fully complies with therequirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934;and

 

(2)           The information contained in theReport fairly presents, in all material respects, the financial condition andresult of operations of the Registrant.

 

 
| /s/ Ken F.  Parsons, Sr.               |   |
|----------------------------------------|--------|
| Ken F.  Parsons, Sr.                   |
| President  and Chief Executive Officer |
|                                   |
|                                   |
| /s/ Thomas  L. Dhamers                 |   |
| Thomas L.  Dhamers                     |
| Vice  President/Controller             |
|                                   |
|                                   |
| March 19,  2003                        |

 

1

----
COURT OF APPEALS

EIGHTH DISTRICT OF TEXAS

EL PASO, TEXAS

HARVEY GEAN EMERSON,

 Appellant,

v.

THE STATE OF TEXAS,

 State.

'

'

'

'

'

'

No. 08-15-00150-CR

Appeal from the

422nd District Court

of Kaufman County, Texas 

(TC# 32044-422)

O R D E R

The Court GRANTS the Appellant’s third motion for extension of time to file the brief 

until October 13, 2015. NO FURTHER MOTIONS FOR EXTENSION OF TIME TO FILE 

THE APPELLANT’S BRIEF WILL BE CONSIDERED BY THIS COURT.

It is further ORDERED that the Hon. Lara Elizabeth Bracamonte, the Appellant’s 

Attorney, prepare the Appellant’s brief and forward the same to this Court on or before October 

13, 2015.

IT IS SO ORDERED this 22nd day of September, 2015.

PER CURIAM

Before McClure, C.J., Rodriguez and Hughes, JJ.
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                                <C>                     <C>
<PERIOD-TYPE>                                    3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1996             DEC-31-1996
<PERIOD-END>                               SEP-30-1996             SEP-30-1996
<CASH>                                      $3,090,274              $3,090,274
<SECURITIES>                                         0                       0
<RECEIVABLES>                                 $181,922                $181,922
<ALLOWANCES>                                         0                       0
<INVENTORY>                                 $2,122,355              $2,122,355
<CURRENT-ASSETS>                            $9,254,492              $9,254,492
<PP&E>                                        $873,555                $873,555
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                             $10,369,962             $10,369,962
<CURRENT-LIABILITIES>                       $5,069,811              $5,069,811
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                          0                       0
<COMMON>                                      $212,011                $212,011
<OTHER-SE>                                  $5,084,937              $5,084,937
<TOTAL-LIABILITY-AND-EQUITY>               $10,369,962             $10,369,962
<SALES>                                     $9,799,568             $30,383,925
<TOTAL-REVENUES>                            $9,799,568             $30,383,925
<CGS>                                       $5,118,776             $15,967,409
<TOTAL-COSTS>                               $9,541,789             $30,207,758
<OTHER-EXPENSES>                                     0                       0
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                               $309,034                $374,060
<INCOME-TAX>                                   $89,000                $108,000
<INCOME-CONTINUING>                           $220,034                $266,060
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                  $220,034                $266,060
<EPS-PRIMARY>                                    $0.10                   $0.12
<EPS-DILUTED>                                    $0.10                   $0.12
        

</TABLE>
Exhibit 32.1

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




        In connection with the Quarterly Report of Berkeley  Technology  Limited
on Form  10-Q  for the  period  ended  March  31,  2004 as  filed  with the U.S.
Securities and Exchange  Commission  (the  "Report"),  I, Arthur I. Trueger,  as
Executive Chairman of the registrant,  certify,  pursuant to 18 U.S.C. ss. 1350,
as adopted by ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

        (1) The Report fully complies with the  requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, and

        (2) The  information  contained in the Report  fairly  presents,  in all
material  respects,  the  financial  condition  and results of operations of the
registrant.



Date:  May 14, 2004                              By:    /s/  Arthur I. Trueger

                                                        Arthur I. Trueger
                                                        Executive Chairman